United States

People: ImmunoGen Inc (IMGN.OQ)

IMGN.OQ on NASDAQ Stock Exchange Global Select Market

22 Sep 2017
Change (% chg)

$0.05 (+0.77%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Lambert, John 

Dr. John M. Lambert, Ph.D. is a nExecutive Vice President - Distinguished Research Fellow of the Company. He joined ImmunoGen in 1987, and has served as Executive Vice President and Distinguished Research Fellow since January 2015. Prior to that he served as our Executive Vice President and Chief Scientific Officer from 2008 through 2014. Dr. Lambert holds a PhD in Biochemistry from University of Cambridge in England, and completed his postdoctoral work at the University of California at Davis and at Glasgow University in Scotland.

Basic Compensation

Total Annual Compensation, USD 560,363
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 1,055,060
Fiscal Year Total, USD 1,615,430

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --